These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 29403271)
21. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease. Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427 [TBL] [Abstract][Full Text] [Related]
22. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. David B; Bafadhel M; Koenderman L; De Soyza A Thorax; 2021 Feb; 76(2):188-195. PubMed ID: 33122447 [TBL] [Abstract][Full Text] [Related]
23. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659 [TBL] [Abstract][Full Text] [Related]
24. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD. Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740 [TBL] [Abstract][Full Text] [Related]
25. Eosinophils in COPD: just another biomarker? Bafadhel M; Pavord ID; Russell REK Lancet Respir Med; 2017 Sep; 5(9):747-759. PubMed ID: 28601554 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD. Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029 [TBL] [Abstract][Full Text] [Related]
27. Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts. Saito Z; Yoshida M; Kojima A; Tamura K; Hasegawa T; Kuwano K Lung; 2020 Dec; 198(6):925-931. PubMed ID: 33068153 [TBL] [Abstract][Full Text] [Related]
28. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis. Cheng SL Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168 [TBL] [Abstract][Full Text] [Related]
29. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility. Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165 [TBL] [Abstract][Full Text] [Related]
30. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD. Kostikas K; Brindicci C; Patalano F Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007 [TBL] [Abstract][Full Text] [Related]
31. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739 [TBL] [Abstract][Full Text] [Related]